Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Rodriguez

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
Frontiers in Immunology|October 5, 2023
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemiaCristina Calviño, Candela Ceballos, Ana Alfonso, et al.
BMJ Quality & Safety|August 15, 2024
Optimising antibacterial utilisation in Argentine intensive care units: a quality improvement collaborativeFacundo Jorro-Baron, Cecilia Inés Loudet, Wanda Cornistein, et al.
Blood|October 8, 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasoneLuca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero, et al.
Hemasphere|December 12, 2024
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experienceVeronica González-Calle, Paula Rodriguez-Otero, Maria J Calasanz, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Door-In-Door-Out Time Effect on Clinical Outcome According to Reperfusion Time in Endovascular TreatmentAlan Flores, Laia SeróMD, Xavier Ustrell, et al.
The Lancet. Oncology|June 3, 2023
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma NetworkHeinz Ludwig, Evangelos Terpos, Niels van de Donk, et al.
FASEB Bioadvances|August 8, 2024
Consequences of gene editing of <i>PRLR</i> on thermotolerance, growth, and male reproduction in cattleCamila J Cuellar, Thiago F Amaral, Paula Rodriguez-Villamil, et al.
Viruses|October 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.
Molecular Ecology Resources|January 1, 2023
A chromosome-level genome assembly enables the identification of the follicule stimulating hormone receptor as the master sex-determining gene in the flatfish Solea senegalensisRoberto de la Herrán, Miguel Hermida, Juan Andres Rubiolo, et al.
The Lancet. Oncology|May 31, 2024
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy CommitteeYi Lin, Lugui Qiu, Saad Usmani, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Frontiers in Immunology|October 5, 2023
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemiaCristina Calviño, Candela Ceballos, Ana Alfonso, et al.
BMJ Quality & Safety|August 15, 2024
Optimising antibacterial utilisation in Argentine intensive care units: a quality improvement collaborativeFacundo Jorro-Baron, Cecilia Inés Loudet, Wanda Cornistein, et al.
Blood|October 8, 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasoneLuca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero, et al.
Hemasphere|December 12, 2024
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experienceVeronica González-Calle, Paula Rodriguez-Otero, Maria J Calasanz, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Door-In-Door-Out Time Effect on Clinical Outcome According to Reperfusion Time in Endovascular TreatmentAlan Flores, Laia SeróMD, Xavier Ustrell, et al.
The Lancet. Oncology|June 3, 2023
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma NetworkHeinz Ludwig, Evangelos Terpos, Niels van de Donk, et al.
FASEB Bioadvances|August 8, 2024
Consequences of gene editing of <i>PRLR</i> on thermotolerance, growth, and male reproduction in cattleCamila J Cuellar, Thiago F Amaral, Paula Rodriguez-Villamil, et al.
Viruses|October 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.
Molecular Ecology Resources|January 1, 2023
A chromosome-level genome assembly enables the identification of the follicule stimulating hormone receptor as the master sex-determining gene in the flatfish Solea senegalensisRoberto de la Herrán, Miguel Hermida, Juan Andres Rubiolo, et al.
The Lancet. Oncology|May 31, 2024
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy CommitteeYi Lin, Lugui Qiu, Saad Usmani, et al.
Pageof 24